SODIUM OXAMATE (C005B-442368)

Catalog No.: C005B-442368
Mfr. No.: O2751-25G
Mfr. Name: Sigma-Aldrich
Qty/UOM: 25
UOM: GM

Price: $1,094.59

List Price: $1,216.22

Application Sodium oxamate has been used: as one of the variable in flow injection analysis in in vitro angiogenesis assay to confirm the stimulatory role of stearic acid on lactate dehydrogenase mediated lactate production

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Application

Sodium oxamate has been used:

as one of the variable in flow injection analysis
in in vitro angiogenesis assay
to confirm the stimulatory role of stearic acid on lactate dehydrogenase mediated lactate production

Biochem/physiol Actions

Sodium oxamate influences the fatty acid metabolism. It might be useful for the treatment of diabetes.

Structural analog of pyruvate, inhibits L(+)-lactate dehydrogenase and derails the entire gluconeogenic pathway. Binding studies with lactate dehydrogenase; Mechanism of inhibition of mitochondrial pyruvate metabolism

UPC:: 51422427
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: O2751-25G
CAS:: 565-73-1

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."